Neuraxis to present at the gilmartin group emerging growth showcase

Carmel, ind., sept. 13, 2023 (globe newswire) -- neuraxis, inc. (nyse american: nrxs), (“neuraxis,” or the “company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today announced that president and chief executive officer brian carrico and chief medical officer dr. adrian miranda, will present at the upcoming gilmartin group emerging growth showcase on thursday, september 21, 2023, at 9:00 am et.
NRXS Ratings Summary
NRXS Quant Ranking